Mode
Text Size
Log in / Sign up

Hypothyroidism

8 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Hypothyroidism

13 trials tracked for Hypothyroidism: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 87 citations.

13Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3 Phase 2 4 Other / NA 6
  1. Phase 4 Neurocognitive and Metabolic Effects of Mild Hypothyroidism Completed · 87 cited
  2. Phase 4 Hypothyroidism Treated With Calcitonin Completed
  3. Phase 4 Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit Completed
  4. Phase 2 Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation Completed
  5. Phase 2 Energy Metabolism in Thyroidectomized Patients Completed
  6. Phase 2 A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants Completed
Show 7 more trials
  1. Phase 2 Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism Completed
  2. N/A Generic vs. Name-Brand Levothyroxine Completed
  3. N/A Swallowing Function Before and After Surgery for Thyroid Goiter Completed
  4. N/A Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure Completed
  5. N/A Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism Completed
  6. N/A Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States Completed
  7. N/A Thyroid Hormone Dose Adjustment in Pregnancy Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Hypothyroidism: what the trials found

L-thyroxine (L-T4) is established as a standard intervention for the management of hypothyroidism 1.

Diagnostic monitoring and assessment in patients with hypothyroidism can be performed using Quantitative POC TSH Kits 3.

Research indicates that iodinated contrast agents are utilized in clinical contexts involving patients with an indication of hypothyroidism; however, baseline characteristics regarding the type of first examination showed significant differences between cases with and without a hypothyroidism indication (p=0.022) 10.

Iodinated contrast agents were also evaluated in large-scale cohorts for use in patients with thyroid conditions 9.

Recent results — preliminary, needs further review

  • Levothyroxine sodium is being investigated as an intervention 4.
  • Armour® Thyroid showed a sustained TSH response in 60.76% and 75.92% of participants, with titration TSH responses observed in 80.62% and 91.13% of patients respectively 6.

For the clinician treating this condition

  • L-thyroxine remains a primary established pharmacological intervention for hypothyroidism 1.
  • Point-of-care (POC) TSH kits are available for monitoring thyroid function in these patients 3.
  • Clinical data suggests that while iodinated contrast agents are used in this patient population, specific baseline characteristics regarding initial examination types may vary significantly between those with and without a confirmed hypothyroidism diagnosis 10.

AI synthesis of 6 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Hypothyroidism

Is levothyroxine approved for TSH suppression in hypothyroidism patients?

Levothyroxine is FDA-approved for TSH suppression only as an adjunct to surgery and radioiodine therapy for well-differentiated thyroid cancer, not for benign thyroid nodules or general hypothyroidism.

Full answer →
What TSH cutoff values are used for preterm infants with hypothyroidism?

TSH cutoff values for preterm infants vary by gestational age, birth weight, and postnatal age; a 2024 study suggests a 97.5th percentile cutoff around 7.38 μIU/mL in the third postnatal week, while older studies use cutoffs like 6 mU/L.

Full answer →
Does having hypothyroidism increase the risk of chronic kidney disease?

Yes, hypothyroidism is associated with a higher prevalence of chronic kidney disease, but the evidence on causing new CKD is less clear.

Full answer →
Can levothyroxine tablets treat primary and secondary hypothyroidism?

Yes, levothyroxine tablets are FDA-approved to treat both primary and secondary hypothyroidism as replacement therapy.

Full answer →